Newest first. 5.2k questions across 107 tags.
Details up front: fatigue · orforglipron · TRIUMPH-1. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
Concretely: SUSTAIN-6 · 30 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which I…
Concretely: early satiety · 1,100 kcal. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident several times…
Concretely: 97.6% · VendorInvestigate · 99.1% · Medutest. I would like the axes of comparison first and the recommendation second. I have tried the first option and…
Conditions: headache · six · retatrutide. I have done this once and I suspect I got away with it rather than got it right. For context: I keep records of every batch,…
Conditions: ecnoglutide · 8 mg/mL. Please show the division. I want to check my own against yours. I would like the general form as well as the specific number, so I…
The case in front of me: HJ · Wuxi · Ireland. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like…
The case in front of me: STEP 2 · reflux. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
For reference: 4 mg · 1 mL. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that differ by a factor of ten,…
The particulars: 40 units · 2.5 mg/mL. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than discover a problem…
The particulars: deamidation · survodutide · minus 80 °C. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I…
The particulars: GGPeps · Guangzhou · the United States. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit…
I am asking about the protocol logic rather than about my own case specifically. I want to understand what this actually establishes, as opposed to what it is being…
For reference: 98.2% · a wide-pore C18 column · a GLP-1 receptor agonist. I want to understand what this actually establishes, as opposed to what it is being used to…
The particulars: AST · ecnoglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules, not…
The lane and the lead time matter as much as the material for what I am doing. I would rather understand the derivation than memorise the outcome. Two people I asked…
Stated plainly: FGP · Shanghai Sigma-Audley. Both of these get recommended confidently by different people, which suggests neither is obviously right. My constraints…
The method section is present, which is unusual enough that I want to make use of it. I keep seeing this stated as a fact with no explanation attached, and…
Stated plainly: lipase · two weeks · semaglutide. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have…
Details up front: 99.4% · retatrutide · GL Biochem. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me…
Details up front: phosphate-buffered diluent · twenty-one days. I would like to understand the steps well enough to explain them to someone else. I have access to a…
Details up front: a GLP-1 receptor agonist · ESSENCE. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring…
Numbers first: Changsha · Ireland. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Numbers first: 8 mg · 5 mL. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I would rather learn…